Mind Medicine (MindMed) Inc. (MNMD) Financial Statements
Industry: Medicinal Chemicals & Botanical Products
In fiscal 2025, Mind Medicine (MindMed) reported revenue of $0. Net income was -$183.8M, or -$2.06 per diluted share. Operating activities generated -$131.6M of cash. At fiscal year end, Mind Medicine (MindMed) held $440.1M in total assets against $107.8M in total liabilities, including $257.8M of cash and equivalents.
Open the full interactive Mind Medicine (MindMed) financials → Quarterly statements, key ratios, valuation history and price charts.
Mind Medicine (MindMed) Key Stats
| Share Price | $34.38 |
|---|---|
| Market Cap | $3.81B |
| 52-Week Range | $10.68 – $48.45 |
| Shares Outstanding | 110.7 million (basic, 2026 Q2) |
Mind Medicine (MindMed) Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$93.9M | -$66.3M | -$93.9M | -$103.9M | -$166.3M |
| Pre-Tax Income | -$94.2M | -$56.8M | -$95.7M | -$108.7M | -$183.8M |
| Income Tax | -$1.2M | — | — | — | $0 |
| Net Income | -$93.0M | -$56.8M | -$95.7M | -$108.7M | -$183.8M |
| Diluted EPS | -$3.45 | -$1.84 | -$2.44 | -$1.54 | -$2.06 |
Mind Medicine (MindMed) Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$67.3M | -$50.4M | -$77.1M | -$159.0M |
| Diluted EPS | -$0.78 | -$0.56 | -$0.71 | -$1.44 |
Mind Medicine (MindMed) Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $133.5M | $142.1M | $99.7M | $273.7M | $257.8M |
| Current Assets | $137.2M | $146.1M | $103.9M | $281.6M | $419.3M |
| Total Assets | $164.0M | $170.0M | $124.5M | $302.2M | $440.1M |
| Current Liabilities | $10.4M | $17.9M | $32.2M | $38.8M | $66.7M |
| Total Long-Term Debt | — | — | $14.1M | $21.9M | $40.6M |
| Total Liabilities | $12.3M | $19.1M | $46.4M | $60.7M | $107.8M |
| Shareholders' Equity | $151.7M | $150.9M | $78.1M | $241.4M | $332.3M |
Mind Medicine (MindMed) Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$45.8M | -$50.1M | -$64.4M | -$79.1M | -$131.6M |
| Cash From Investing | -$297,000 | — | — | — | -$151.6M |
| Cash From Financing | $98.8M | $59.1M | $21.8M | $253.2M | $267.3M |
Figures from Mind Medicine (MindMed)'s 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Mind Medicine (MindMed) financials page for every line item.
Mind Medicine (MindMed) Company Profile
| Ticker | MNMD |
|---|---|
| Exchange | Nasdaq |
| Industry | Medicinal Chemicals & Botanical Products |
| Headquarters | New York, New York |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001813814 |
Frequently Asked Questions
What was Mind Medicine (MindMed)'s revenue in fiscal 2025?
Mind Medicine (MindMed) (MNMD) reported revenue of $0 for fiscal 2025.
What is Mind Medicine (MindMed)'s annual revenue history?
Mind Medicine (MindMed)'s annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Mind Medicine (MindMed)'s net income in fiscal 2025?
Mind Medicine (MindMed) reported net income of -$183.8M for fiscal 2025.
What was Mind Medicine (MindMed)'s earnings per share (EPS) in fiscal 2025?
Mind Medicine (MindMed)'s diluted EPS was -$2.06 for fiscal 2025 (adjusted for any later stock splits).
What was Mind Medicine (MindMed)'s revenue last quarter?
In its most recent reported quarter (2026 Q2), Mind Medicine (MindMed) reported revenue of $0.
How much debt does Mind Medicine (MindMed) have?
Mind Medicine (MindMed) reported $40.6M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Mind Medicine (MindMed) are outstanding?
Mind Medicine (MindMed) reported a weighted average of 110.7 million basic shares outstanding in 2026 Q2.
What is Mind Medicine (MindMed)'s market cap?
Based on its latest closing price, Mind Medicine (MindMed) (MNMD) has a market capitalization of about $3.81B.
When does Mind Medicine (MindMed)'s fiscal year end?
Mind Medicine (MindMed)'s fiscal year end, as registered with the SEC, is December 31.
Where is Mind Medicine (MindMed) headquartered?
Mind Medicine (MindMed) lists its business address in New York, New York in its SEC filings.
Mind Medicine (MindMed) Competitors & Similar Companies
See all 11 Medicinal Chemicals & Botanical Products companies →